No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Renagel is a drug used to treat kidney and liver disorders. It is a phosphate binder, meaning it binds to phosphate in the digestive tract and prevents it from being absorbed into the bloodstream. This helps to reduce the amount of phosphate in the blood, which can help to reduce the symptoms of kidney and liver disorders. Renagel is typically prescribed to patients with chronic kidney disease, end-stage renal disease, and hyperphosphatemia. It is available in tablet form and is taken orally.
Renagel is a relatively new drug, having been approved by the FDA in 1997. It is manufactured by Genzyme Corporation, a subsidiary of Sanofi. Other companies that produce phosphate binders include Shire, Fresenius Medical Care, and Keryx Biopharmaceuticals. Show Less Read more
